
Amprius Technologies, Inc. (NYSE:AMPX – Free Report) – Analysts at HC Wainwright lowered their FY2026 earnings estimates for Amprius Technologies in a report released on Friday, May 8th. HC Wainwright analyst A. Dayal now expects that the company will earn ($0.07) per share for the year, down from their prior forecast of ($0.06). The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.07) per share. HC Wainwright also issued estimates for Amprius Technologies’ FY2027 earnings at $0.01 EPS and FY2028 earnings at $0.18 EPS.
Several other equities analysts have also weighed in on AMPX. Northland Securities set a $24.00 price objective on shares of Amprius Technologies in a research report on Monday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Monday, April 20th. Cantor Fitzgerald lifted their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Needham & Company LLC reissued a “buy” rating and issued a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Finally, Roth Mkm reissued a “buy” rating on shares of Amprius Technologies in a research report on Friday. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $20.25.
Amprius Technologies Stock Performance
Shares of AMPX opened at $17.72 on Tuesday. The firm has a market cap of $2.43 billion, a PE ratio of -59.05 and a beta of 2.20. The firm’s 50 day moving average price is $17.77 and its 200 day moving average price is $13.31. Amprius Technologies has a twelve month low of $2.34 and a twelve month high of $22.80.
Amprius Technologies (NYSE:AMPX – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $28.54 million for the quarter, compared to the consensus estimate of $25.72 million. Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%.
Institutional Investors Weigh In On Amprius Technologies
Several hedge funds and other institutional investors have recently modified their holdings of the stock. AlphaCentric Advisors LLC grew its stake in shares of Amprius Technologies by 20.0% in the first quarter. AlphaCentric Advisors LLC now owns 60,000 shares of the company’s stock worth $1,012,000 after acquiring an additional 10,000 shares during the last quarter. KBC Group NV acquired a new stake in shares of Amprius Technologies in the first quarter worth $57,000. Swiss National Bank grew its stake in shares of Amprius Technologies by 4.7% in the first quarter. Swiss National Bank now owns 232,400 shares of the company’s stock worth $3,918,000 after acquiring an additional 10,400 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Amprius Technologies by 700.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company’s stock worth $6,695,000 after acquiring an additional 377,485 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in shares of Amprius Technologies by 60.9% in the first quarter. Geneos Wealth Management Inc. now owns 17,140 shares of the company’s stock worth $289,000 after acquiring an additional 6,490 shares during the last quarter. Institutional investors and hedge funds own 5.04% of the company’s stock.
Insider Activity
In other news, CTO Constantin Ionel Stefan sold 25,366 shares of Amprius Technologies stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the transaction, the chief technology officer owned 723,330 shares of the company’s stock, valued at $7,349,032.80. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kang Sun sold 1,500,000 shares of Amprius Technologies stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the completion of the transaction, the director directly owned 1,342,400 shares in the company, valued at approximately $21,357,584. This represents a 52.77% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 2,539,829 shares of company stock worth $42,323,376. 12.90% of the stock is owned by company insiders.
Amprius Technologies News Summary
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Northland Securities raised its Q4 2027 EPS estimate for Amprius Technologies to $0.03 from $0.02, signaling slightly better profitability expectations ahead. Northland Securities estimate update
- Positive Sentiment: Northland also lifted its FY2028 EPS forecast to $0.23, reinforcing optimism that AMPX could move further into the black over time. Northland Securities FY2028 estimate update
- Neutral Sentiment: Northland trimmed its Q2 2027 EPS estimate to $0.00 from $0.01 and kept its Q4 2026 view at a small loss, showing the near-term path remains uneven. Northland Securities near-term estimate update
- Neutral Sentiment: HC Wainwright lowered its FY2026 and FY2027 earnings estimates, while still projecting eventual profitability, which points to mixed sentiment rather than a clear negative catalyst. HC Wainwright estimate update
- Neutral Sentiment: The consensus full-year EPS estimate remains at a loss of $0.07, so the company is still expected to lose money in the current year despite better long-term forecasts. Consensus estimate
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
See Also
- Five stocks we like better than Amprius Technologies
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
